Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Merlin

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
Cellular and Molecular Life Sciences : CMLS|March 31, 2012
Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98Hang Thi Thu Nguyen, Didier Merlin
Nanomedicine (London, England)|July 18, 2020
Genetically modified silk fibroin nanoparticles for drug delivery: preparation strategies and application prospectsDingpei Long, Bo Xiao, Didier Merlin
Nanomedicine (London, England)|November 5, 2016
Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?Mingzhen Zhang, James F Collins, Didier Merlin
Methods in Enzymology|May 10, 2012
Gastrointestinal delivery of anti-inflammatory nanoparticlesHamed Laroui, Shanthi V Sitaraman, Didier Merlin
Gastroenterology|December 7, 2007
Quality is as important as the quantity: role of mucin glycosylation on intestinal barrier functionAnupama Ravi, Didier Merlin, Shanthi V Sitaraman
World Journal of Gastroenterology|September 29, 2016
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseXiao-Ying Si, Didier Merlin, Bo Xiao
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2017
MiRNA Quantitation with Microelectrode Sensors Enabled by Enzymeless Electrochemical Signal AmplificationTanyu Wang, Gangli Wang, Didier Merlin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 7, 2006
Characterization of the human intestinal CD98 promoter and its regulation by interferon-gammaYutao Yan, Guillaume Dalmasso, Shanthi Sitaraman, et al.
Gastroenterology|January 24, 2007
Keeping harmful intruders at bay: insights into the mechanism of barrier dysfunction during inflammatory bowel diseasesArianne L Theiss, Didier Merlin, Shanthi V Sitaraman
Nanomedicine (London, England)|November 1, 2022
Lipid nanoparticles for oral delivery of nucleic acids for treating inflammatory bowel diseaseChunhua Yang, Gianfranco Alpini, Shannon Glaser, et al.
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
Cellular and Molecular Life Sciences : CMLS|March 31, 2012
Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98Hang Thi Thu Nguyen, Didier Merlin
Nanomedicine (London, England)|July 18, 2020
Genetically modified silk fibroin nanoparticles for drug delivery: preparation strategies and application prospectsDingpei Long, Bo Xiao, Didier Merlin
Nanomedicine (London, England)|November 5, 2016
Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?Mingzhen Zhang, James F Collins, Didier Merlin
Methods in Enzymology|May 10, 2012
Gastrointestinal delivery of anti-inflammatory nanoparticlesHamed Laroui, Shanthi V Sitaraman, Didier Merlin
Gastroenterology|December 7, 2007
Quality is as important as the quantity: role of mucin glycosylation on intestinal barrier functionAnupama Ravi, Didier Merlin, Shanthi V Sitaraman
World Journal of Gastroenterology|September 29, 2016
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseXiao-Ying Si, Didier Merlin, Bo Xiao
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2017
MiRNA Quantitation with Microelectrode Sensors Enabled by Enzymeless Electrochemical Signal AmplificationTanyu Wang, Gangli Wang, Didier Merlin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 7, 2006
Characterization of the human intestinal CD98 promoter and its regulation by interferon-gammaYutao Yan, Guillaume Dalmasso, Shanthi Sitaraman, et al.
Gastroenterology|January 24, 2007
Keeping harmful intruders at bay: insights into the mechanism of barrier dysfunction during inflammatory bowel diseasesArianne L Theiss, Didier Merlin, Shanthi V Sitaraman
Nanomedicine (London, England)|November 1, 2022
Lipid nanoparticles for oral delivery of nucleic acids for treating inflammatory bowel diseaseChunhua Yang, Gianfranco Alpini, Shannon Glaser, et al.
Pageof 20